SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients
…, SCL Almeida, FR Oliveira, MN Benatti… - Journal of Molecular …, 2022 - academic.oup.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated
with a hyperinflammatory state and lymphocytopenia, a hallmark that appears as both …
with a hyperinflammatory state and lymphocytopenia, a hallmark that appears as both …
[HTML][HTML] Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
Severe cases of COVID-19 are characterized by a strong inflammatory process that may
ultimately lead to organ failure and patient death. The NLRP3 inflammasome is a molecular …
ultimately lead to organ failure and patient death. The NLRP3 inflammasome is a molecular …
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
…, PI Menezes, SM Dib, SL Gigante, MN Benatti… - RMD open, 2021 - rmdopen.bmj.com
Objective To evaluate whether the addition of colchicine to standard treatment for COVID-19
results in better outcomes. Design We present the results of a randomised, double-blinded, …
results in better outcomes. Design We present the results of a randomised, double-blinded, …
Infection of human lymphomononuclear cells by SARS-CoV-2
…, RL Assad, SCL Almeida, FR Oliveira, MN Benatti… - BioRxiv, 2020 - biorxiv.org
Although SARS-CoV-2 severe infection is associated with a hyperinflammatory state,
lymphopenia is an immunological hallmark, and correlates with poor prognosis in COVID-19. …
lymphopenia is an immunological hallmark, and correlates with poor prognosis in COVID-19. …
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage
…, RB Martins, RA Santos-Eichler, MN Benatti… - Vascular …, 2022 - Elsevier
Background and purpose Mitochondria play a central role in the host response to viral infection
and immunity, being key to antiviral signaling and exacerbating inflammatory processes. …
and immunity, being key to antiviral signaling and exacerbating inflammatory processes. …
Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial
…, LP Bonjorno, MC Giannini, NB Amaral, MN Benatti… - MedRxiv, 2020 - medrxiv.org
Introduction Neutrophilia and high levels of proinflammatory cytokines and other mediators
of inflammation are common finds in patients with severe acute respiratory syndrome due to …
of inflammation are common finds in patients with severe acute respiratory syndrome due to …
Inflammasome activation in COVID-19 patients
…, MC Giannini, LP Bonjorno, MIF Lopes, MN Benatti… - MedRxiv, 2020 - medrxiv.org
Severe cases of COVID-19 are characterized by a strong inflammatory process that may
ultimately lead to organ failure and patient death. The NLRP3 inflammasome is a molecular …
ultimately lead to organ failure and patient death. The NLRP3 inflammasome is a molecular …
Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients
The severe forms and worsened outcomes of COVID-19 (coronavirus disease 19) are
closely associated with hypertension and cardiovascular disease. Endothelial cells express …
closely associated with hypertension and cardiovascular disease. Endothelial cells express …
Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells
…, MC Giannini, LP Bonjorno, MIF Lopes, MN Benatti… - Elife, 2022 - elifesciences.org
COVID-19 is a disease of dysfunctional immune responses, but the mechanisms triggering
immunopathogenesis are not established. The functional plasticity of macrophages allows …
immunopathogenesis are not established. The functional plasticity of macrophages allows …
COVID‐19 bimodal clinical and pathological phenotypes
Dear Editor, For the first time to our knowledge, we describe a bimodal phenotype of
coronavirus disease 2019 (COVID-19) patients provided by clinical and pathological correlation …
coronavirus disease 2019 (COVID-19) patients provided by clinical and pathological correlation …
